Article
Clinical efficacy of recombinant versus highly purified follicle-stimulating hormone according to follicle-stimulating hormone receptor genotype.
Pharmacogenetics and genomics - 1 Jun 2016
Lledó Belén, Dapena Patricia, Ortiz Jose A, Morales Ruth, Llacer Joaquín, Bernabeu Rafael
Abstract excerpt
OBJECTIVE: Conflicting data have been reported on the comparative doses of recombinant follicle-stimulating hormone (rFSH) and urinary highly purified follicle-stimulating hormone (HP-FSH) required for ovarian stimulation. Nothing is known about the clinical efficacy of rFSH or HP-FSH depending on the N680S follicle-stimulating hormone receptor (FSHR) polymorphism. Our aim was to investigate whether the N680S...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
